Connection

Charles Kellner to Rituximab

Back to Details
This is a "connection" page, showing publications Charles Kellner has written about Rituximab.
Charles Kellner
Connection Strength
0.092
Rituximab
  1. Prolonged succinylcholine action during electroconvulsive therapy (ECT) after cytarabine, vincristine, and rituximab chemotherapy. J ECT. 2011 Mar; 27(1):e42-3.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.